Veradigm (NASDAQ:MDRX) Shares Down 4.5% – Here’s Why

Veradigm Inc. (NASDAQ:MDRX)’s stock price was down 4.5% on Friday . The company traded as low as $9.00 and last traded at $9.75. Approximately 30,741 shares traded hands during trading, a decline of 98% from the average daily volume of 1,502,042 shares. The stock had previously closed at $10.21.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of Veradigm in a research note on Wednesday. They set a “hold” rating on the stock. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $11.75.

Veradigm Stock Down 2.1 %

The business has a 50 day simple moving average of $9.96 and a 200-day simple moving average of $9.73.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new position in shares of Veradigm Inc. (NASDAQ:MDRX) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.